No Data
No Data
No Data
No Data
No Data
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (NASDAQ:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today announced that six
GlobeNewswireApr 23 05:31
Generation Bio Price Target Maintained With a $10.00/Share by Needham
Generation Bio Price Target Maintained With a $10.00/Share by Needham
Dow JonesApr 10 18:31
Needham: Reiterates Generation Bio (GBIO.US) rating and adjusted from buy to buy rating, target price is $10.00.
Needham: Reiterates Generation Bio (GBIO.US) rating and adjusted from buy to buy rating, target price is $10.00.
Zhitong FinanceApr 10 18:30
Analysts Are Bullish on These Healthcare Stocks: Generation Bio (GBIO), Poseida Therapeutics (PSTX)
TipRanksApr 10 18:30
Needham Reiterates Buy on Generation Bio, Maintains $10 Price Target
Needham analyst Gil Blum reiterates Generation Bio (NASDAQ:GBIO) with a Buy and maintains $10 price target.
BenzingaApr 10 18:24
Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference
CAMBRIDGE, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announc
GlobeNewswireApr 2 18:59
No Data
No Data